[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Respiratory Tract Infections (Respiratory) - Drugs in Development, 2021

 US$ 2,000.00

Respiratory Tract Infections (Respiratory) - Drugs in Development, 2021 SUMMARY Respiratory Tract Infections (Respiratory) - Drugs in Development, 2021 provides an overview of the Respiratory Tract In...

April 2021 40 pages

Respiratory Tract Inflammatory Disorders (Respiratory) - Drugs in Development, 2021

 US$ 2,000.00

Respiratory Tract Inflammatory Disorders (Respiratory) - Drugs in Development, 2021 SUMMARY Respiratory Tract Inflammatory Disorders (Respiratory) - Drugs in Development, 2021 provides an overview of...

April 2021 35 pages

Retinal Degeneration (Ophthalmology) - Drugs in Development, 2021

 US$ 2,000.00

Retinal Degeneration (Ophthalmology) - Drugs in Development, 2021 SUMMARY Retinal Degeneration (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Retinal Degeneration pipeline la...

April 2021 50 pages

Retinoic Acid Receptor (RAR) - Drugs in Development, 2021

 US$ 3,000.00

Retinoic Acid Receptor (RAR) - Drugs in Development, 2021 SUMMARY Retinoic Acid Receptor (RAR) - Drugs in Development, 2021 provides in depth analysis on Retinoic Acid Receptor (RAR) targeted pipeline...

April 2021 35 pages

Retinoid X Receptor (RXR) - Drugs in Development, 2021

 US$ 3,000.00

Retinoid X Receptor (RXR) - Drugs in Development, 2021 SUMMARY Retinoid X Receptor (RXR) - Drugs in Development, 2021 provides in depth analysis on Retinoid X Receptor (RXR) targeted pipeline therapeu...

April 2021 30 pages

Retinopathy (Ophthalmology) - Drugs in Development, 2021

 US$ 2,000.00

Retinopathy (Ophthalmology) - Drugs in Development, 2021 SUMMARY Retinopathy (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Retinopathy pipeline landscape. The report provide...

April 2021 40 pages

Reverse Transcriptase (EC 2.7.7.49) - Drugs in Development, 2021

 US$ 3,000.00

Reverse Transcriptase (EC 2.7.7.49) - Drugs in Development, 2021 SUMMARY Reverse Transcriptase (EC 2.7.7.49) - Drugs in Development, 2021 provides in depth analysis on Reverse Transcriptase (EC 2.7.7....

April 2021 100 pages

Rhinitis (Ear Nose Throat Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Rhinitis (Ear Nose Throat Disorders) - Drugs in Development, 2021 SUMMARY Rhinitis (Ear Nose Throat Disorders) - Drugs in Development, 2021 provides an overview of the Rhinitis pipeline landscape. The...

April 2021 30 pages

Rhinosinusitis (Ear Nose Throat Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Rhinosinusitis (Ear Nose Throat Disorders) - Drugs in Development, 2021 SUMMARY Rhinosinusitis (Ear Nose Throat Disorders) - Drugs in Development, 2021 provides an overview of the Rhinosinusitis pipel...

April 2021 50 pages

Rho Kinase (Rho Associated Coiled Coil Forming Protein Kinase or ROCK or EC 2.7.11.1) - Drugs in Development, 2021

 US$ 3,000.00

Rho Kinase (Rho Associated Coiled Coil Forming Protein Kinase or ROCK or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Rho Kinase (Rho Associated Coiled Coil Forming Protein Kinase or ROCK or EC 2...

April 2021 50 pages

Rhodopsin (Opsin 2 or OPN2 or RHO) - Drugs in Development, 2021

 US$ 3,000.00

Rhodopsin (Opsin 2 or OPN2 or RHO) - Drugs in Development, 2021 SUMMARY Rhodopsin (Opsin 2 or OPN2 or RHO) - Drugs in Development, 2021 provides in depth analysis on Rhodopsin (Opsin 2 or OPN2 or RHO)...

April 2021 30 pages

Ribonucleoside Diphosphate Reductase (Ribonucleotide Reductase or RRM or EC 1.17.4.1) - Drugs in Development, 2021

 US$ 3,000.00

Ribonucleoside Diphosphate Reductase (Ribonucleotide Reductase or RRM or EC 1.17.4.1) - Drugs in Development, 2021 SUMMARY Ribonucleoside Diphosphate Reductase (Ribonucleotide Reductase or RRM or EC 1...

April 2021 65 pages

Rift Valley Fever (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Rift Valley Fever (Infectious Disease) - Drugs in Development, 2021 SUMMARY Rift Valley Fever (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Rift Valley Fever pipeline l...

April 2021 30 pages

RNA Directed RNA Polymerase (EC 2.7.7.48) - Drugs in Development, 2021

 US$ 3,000.00

RNA Directed RNA Polymerase (EC 2.7.7.48) - Drugs in Development, 2021 SUMMARY RNA Directed RNA Polymerase (EC 2.7.7.48) - Drugs in Development, 2021 provides in depth analysis on RNA Directed RNA Pol...

April 2021 50 pages

RNA Polymerase I (RNAP I or Pol I or EC 2.7.7.6) - Drugs in Development, 2021

 US$ 3,000.00

RNA Polymerase I (RNAP I or Pol I or EC 2.7.7.6) - Drugs in Development, 2021 SUMMARY RNA Polymerase I (RNAP I or Pol I or EC 2.7.7.6) - Drugs in Development, 2021 provides in depth analysis on RNA Po...

April 2021 30 pages

Salivary Gland Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Salivary Gland Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Salivary Gland Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Salivary Gland Cancer pipeline landscape...

April 2021 70 pages

Salmonella Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Salmonella Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Salmonella Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Salmonella Infection...

April 2021 35 pages

Salmonella typhimurium Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Salmonella typhimurium Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Salmonella typhimurium Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of...

April 2021 30 pages

Sarcoidosis (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

Sarcoidosis (Immunology) - Drugs in Development, 2021 SUMMARY Sarcoidosis (Immunology) - Drugs in Development, 2021 provides an overview of the Sarcoidosis pipeline landscape. The report provides comp...

April 2021 45 pages

Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase 2 (Calcium Pump 2 or Calcium Transporting ATPase Sarcoplasmic Reticulum Type Slow Twitch Skeletal Muscle Isoform or Endoplasmic Reticulum Class 1/2 Ca(2+) ATPase or SERCA2 or ATP2A2 or EC 7.2.2.10) - Drugs in Development, 2021

 US$ 3,000.00

Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase 2 (Calcium Pump 2 or Calcium Transporting ATPase Sarcoplasmic Reticulum Type Slow Twitch Skeletal Muscle Isoform or Endoplasmic Reticulum Class 1/2 Ca...

April 2021 35 pages

Scar (Dermatology) - Drugs in Development, 2021

 US$ 2,000.00

Scar (Dermatology) - Drugs in Development, 2021 SUMMARY Scar (Dermatology) - Drugs in Development, 2021 provides an overview of the Scar pipeline landscape. The report provides comprehensive informati...

April 2021 55 pages

Schistosomiasis mansoni Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Schistosomiasis mansoni Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Schistosomiasis mansoni Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview o...

April 2021 30 pages

Schizoaffective Disorder (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Schizoaffective Disorder (Central Nervous System) - Drugs in Development, 2021 SUMMARY Schizoaffective Disorder (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Schizo...

April 2021 30 pages

Schwannoma (Non Malignant Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Schwannoma (Non Malignant Disorders) - Drugs in Development, 2021 SUMMARY Schwannoma (Non Malignant Disorders) - Drugs in Development, 2021 provides an overview of the Schwannoma pipeline landscape. T...

April 2021 30 pages

Sciatica (Sciatic Pain) (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Sciatica (Sciatic Pain) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Sciatica (Sciatic Pain) (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Sciatica...

April 2021 35 pages

Sclerostin (SOST) - Drugs in Development, 2021

 US$ 3,000.00

Sclerostin (SOST) - Drugs in Development, 2021 SUMMARY Sclerostin (SOST) - Drugs in Development, 2021 provides in depth analysis on Sclerostin (SOST) targeted pipeline therapeutics. The report provide...

April 2021 35 pages

Seasonal Allergic Rhinitis (Respiratory) - Drugs in Development, 2021

 US$ 2,000.00

Seasonal Allergic Rhinitis (Respiratory) - Drugs in Development, 2021 SUMMARY Seasonal Allergic Rhinitis (Respiratory) - Drugs in Development, 2021 provides an overview of the Seasonal Allergic Rhinit...

April 2021 40 pages

Seasonal Influenza (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Seasonal Influenza (Infectious Disease) - Drugs in Development, 2021 SUMMARY Seasonal Influenza (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Seasonal Influenza pipelin...

April 2021 105 pages

Secondary CNS Lymphoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Secondary CNS Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Secondary CNS Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Secondary CNS Lymphoma pipeline landsc...

April 2021 35 pages

Secondary Progressive Multiple Sclerosis (SPMS) (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Secondary Progressive Multiple Sclerosis (SPMS) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Secondary Progressive Multiple Sclerosis (SPMS) (Central Nervous System) - Drugs in Develo...

April 2021 75 pages

Seizures (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Seizures (Central Nervous System) - Drugs in Development, 2021 SUMMARY Seizures (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Seizures pipeline landscape. The repor...

April 2021 70 pages

Semaphorin 3A (Semaphorin III or Collapsin 1 or Semaphorin D or Semaphorin L or SEMA3A) - Drugs in Development, 2021

 US$ 3,000.00

Semaphorin 3A (Semaphorin III or Collapsin 1 or Semaphorin D or Semaphorin L or SEMA3A) - Drugs in Development, 2021 SUMMARY Semaphorin 3A (Semaphorin III or Collapsin 1 or Semaphorin D or Semaphorin...

April 2021 30 pages

Sepsis (Infectious Disease) - Drugs in Development, 2021

 US$ 2,500.00

Sepsis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Sepsis (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Sepsis pipeline landscape. The report provides com...

April 2021 230 pages

Septic Shock (Other Diseases) - Drugs in Development, 2021

 US$ 2,000.00

Septic Shock (Other Diseases) - Drugs in Development, 2021 SUMMARY Septic Shock (Other Diseases) - Drugs in Development, 2021 provides an overview of the Septic Shock pipeline landscape. The report pr...

April 2021 50 pages

Serine/Threonine Protein Kinase B Raf (p94 or Proto Oncogene B Raf or v Raf Murine Sarcoma Viral Oncogene Homolog B1 or BRAF or EC 2.7.11.1) - Drugs in Development, 2021

 US$ 3,000.00

Serine/Threonine Protein Kinase B Raf (p94 or Proto Oncogene B Raf or v Raf Murine Sarcoma Viral Oncogene Homolog B1 or BRAF or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Serine/Threonine Prote...

April 2021 85 pages

Serine/Threonine Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or Cell Cycle Checkpoint Kinase or CHEK1 or EC 2.7.11.1) - Drugs in Development, 2021

 US$ 3,000.00

Serine/Threonine Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or Cell Cycle Checkpoint Kinase or CHEK1 or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Serine/Threonine Prot...

April 2021 40 pages

Serine/Threonine Protein Kinase DCLK1 (Doublecortin Domain Containing Protein 3A or Doublecortin Like And CAM Kinase Like 1 or Doublecortin Like Kinase 1 or DCLK1 or EC 2.7.11.1) - Drugs in Development, 2021

 US$ 3,000.00

Serine/Threonine Protein Kinase DCLK1 (Doublecortin Domain Containing Protein 3A or Doublecortin Like And CAM Kinase Like 1 or Doublecortin Like Kinase 1 or DCLK1 or EC 2.7.11.1) - Drugs in Developmen...

April 2021 30 pages

Serine/Threonine Protein Kinase Pim (Pim Kinase or PIM or EC 2.7.11.1) - Drugs in Development, 2021

 US$ 3,000.00

Serine/Threonine Protein Kinase Pim (Pim Kinase or PIM or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Serine/Threonine Protein Kinase Pim (Pim Kinase or PIM or EC 2.7.11.1) - Drugs in Developmen...

April 2021 30 pages

Serine/Threonine Protein Kinase SIK2 (Qin Induced Kinase or Salt Inducible Kinase 2 or Serine/Threonine Protein Kinase SNF1 Like Kinase 2 or SIK2 or EC 2.7.11.1) - Drugs in Development, 2021

 US$ 3,000.00

Serine/Threonine Protein Kinase SIK2 (Qin Induced Kinase or Salt Inducible Kinase 2 or Serine/Threonine Protein Kinase SNF1 Like Kinase 2 or SIK2 or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY S...

April 2021 35 pages

Serine/Threonine Protein Kinase SIK3 (Salt Inducible Kinase 3 or Serine/Threonine Protein Kinase QSK or SIK3 or EC 2.7.11.1) - Drugs in Development, 2021

 US$ 3,000.00

Serine/Threonine Protein Kinase SIK3 (Salt Inducible Kinase 3 or Serine/Threonine Protein Kinase QSK or SIK3 or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Serine/Threonine Protein Kinase SIK3 (...

April 2021 35 pages

Serine/Threonine Protein Kinase/Endoribonuclease IRE1 (Endoplasmic Reticulum To Nucleus Signaling 1 or Inositol Requiring Protein 1 or Ire1 Alpha or Endoribonuclease or ERN1 or EC 2.7.11.1 or EC 3.1.26.) - Drugs in Development, 2021

 US$ 3,000.00

Serine/Threonine Protein Kinase/Endoribonuclease IRE1 (Endoplasmic Reticulum To Nucleus Signaling 1 or Inositol Requiring Protein 1 or Ire1 Alpha or Endoribonuclease or ERN1 or EC 2.7.11.1 or EC 3.1.2...

April 2021 30 pages

Serum Albumin (ALB) - Drugs in Development, 2021

 US$ 3,000.00

Serum Albumin (ALB) - Drugs in Development, 2021 SUMMARY Serum Albumin (ALB) - Drugs in Development, 2021 provides in depth analysis on Serum Albumin (ALB) targeted pipeline therapeutics. The report p...

April 2021 30 pages

Severe Combined Immune Deficiency (SCID) (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Severe Combined Immune Deficiency (SCID) (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Severe Combined Immune Deficiency (SCID) (Genetic Disorders) - Drugs in Development, 2021 provides an...

April 2021 35 pages

Sezary Syndrome (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Sezary Syndrome (Oncology) - Drugs in Development, 2021 SUMMARY Sezary Syndrome (Oncology) - Drugs in Development, 2021 provides an overview of the Sezary Syndrome pipeline landscape. The report provi...

April 2021 55 pages

Short Transient Receptor Potential Channel 5 (Transient Receptor Protein 5 or TRPC5) - Drugs in Development, 2021

 US$ 3,000.00

Short Transient Receptor Potential Channel 5 (Transient Receptor Protein 5 or TRPC5) - Drugs in Development, 2021 SUMMARY Short Transient Receptor Potential Channel 5 (Transient Receptor Protein 5 or...

April 2021 30 pages

Signal Transducer And Activator Of Transcription 3 (Acute Phase Response Factor or DNA Binding Protein APRF or STAT3) - Drugs in Development, 2021

 US$ 3,000.00

Signal Transducer And Activator Of Transcription 3 (Acute Phase Response Factor or DNA Binding Protein APRF or STAT3) - Drugs in Development, 2021 SUMMARY Signal Transducer And Activator Of Transcript...

April 2021 110 pages

Signal Transducer And Activator Of Transcription 5 (STAT5) - Drugs in Development, 2021

 US$ 3,000.00

Signal Transducer And Activator Of Transcription 5 (STAT5) - Drugs in Development, 2021 SUMMARY Signal Transducer And Activator Of Transcription 5 (STAT5) - Drugs in Development, 2021 provides in dept...

April 2021 30 pages

Simplexvirus (HSV) Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Simplexvirus (HSV) Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Simplexvirus (HSV) Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Simp...

April 2021 70 pages

Sirtuin (SIRT or EC 2.3.1.) - Drugs in Development, 2021

 US$ 3,000.00

Sirtuin (SIRT or EC 2.3.1.) - Drugs in Development, 2021 SUMMARY Sirtuin (SIRT or EC 2.3.1.) - Drugs in Development, 2021 provides in depth analysis on Sirtuin (SIRT or EC 2.3.1.) targeted pipeline th...

April 2021 30 pages

Skin Infections (Dermatology) - Drugs in Development, 2021

 US$ 2,000.00

Skin Infections (Dermatology) - Drugs in Development, 2021 SUMMARY Skin Infections (Dermatology) - Drugs in Development, 2021 provides an overview of the Skin Infections pipeline landscape. The report...

April 2021 45 pages

Filters

Clear all

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1